• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

Stock Closed at 52.75


<



Duh, nice investigative work Sherlock. If you look at ALL the equity markets across the globe, they are down. You expect the almighty NVS to buck the trend and go higher?? Are you looking to scalp a few bucks, sure go short. But wisdom says that NVS is in an enviable position with it's pipeline and CASH.
 
















Similar threads

Replies
1
Views
634
Novartis
anonymous
Replies
141
Views
37K
Novartis
anonymous
Replies
27
Views
6K